How Breast Cancer Drug Kadcyla (T-DM1) Works

Kadcyla, also referred to as T-DM1, is a targeted therapy for breast cancer treatment. In this video, oncologist Dr. Stephen Lemon describes how this FDA approved treatment works, as well as what types of side-effects it may cause.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email